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Correction to: Dexamethasone for adult
patients with a symptomatic chronic
subdural haematoma (Dex-CSDH) trial:
study protocol for a randomised controlled
trial
Angelos G. Kolias1,2*†, Ellie Edlmann1,2*†, Eric P. Thelin1,3, Diederik Bulters4, Patrick Holton4, Nigel Suttner5,
Kevin Owusu-Agyemang5, Yahia Z. Al-Tamimi6, Daniel Gatt6, Simon Thomson7, Ian A. Anderson7, Oliver Richards7,
Peter Whitfield8, Monica Gherle8, Karen Caldwell2, Carol Davis-Wilkie9, Silvia Tarantino2, Garry Barton10,
Hani J. Marcus11, Aswin Chari12, Paul Brennan13, Antonio Belli14, Simon Bond9,15, Carole Turner1,2,
Lynne Whitehead16, Ian Wilkinson9, Peter J. Hutchinson1,2* and British Neurosurgical Trainee Research Collaborative
(BNTRC) and Dex-CSDH Trial Collaborators
Correction to: Trials (2018) 19:670
https://doi.org/10.1186/s13063-018-3050-4
After publication of the original article [1], the authors
notified that that one of the BNTRC institutional collab-
orator names was misspelled. Both incorrect and correct
spellings are presented below.
 Originally published name
Ardalan Zolnouria
 Correct name spelling
Ardalan Zolnourian
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